Spencer Moore

Spencer Moore is a skilled QC Manager with extensive experience in method lifecycle management within the biotechnology sector. Currently serving at Bristol Myers Squibb since June 2025, Spencer previously held roles at 2seventy bio where responsibilities included managing QC methods for Abecma® CAR T-cell therapy and overseeing direct reports in the QC lab. Prior experience at bluebird bio involved supporting viral vector testing for multiple gene therapies and leading method qualification activities. With a foundation in quality science gained through various roles, including at Histogenics Corporation, Spencer has developed expertise in qPCR and ELISA methods, and has successfully contributed to inspection readiness and method validation projects. Educational achievements include a Master of Science in Bioinformatics from Brandeis University and a Bachelor’s Degree in Biochemistry and Molecular Biology from the University of Massachusetts Amherst.